You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Talimogene laherparepvec

Showing 1 - 25 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),

Recruiting
  • Sarcoma
  • +2 more
  • Stanford, California
  • +1 more
Feb 2, 2023

Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Stage IV Peritoneal Surface Dissemination From Gastrointestinal or Recurrent, Platinum-resistant Ovarian Cancer That Cannot be

Completed
  • Stage IV Peritoneal Surface Dissemination From Gastrointestinal or Recurrent, Platinum-resistant Ovarian Cancer That Cannot be Completely Resected
  • Talimogene Laherparepvec
  • Chicago, Illinois
  • +2 more
Nov 17, 2022

Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)

Active, not recruiting
  • Breast Cancer
  • Barcelona, Spain
  • +3 more
Sep 27, 2022

Soft Tissue Sarcoma Trial in Iowa City (Talimogene Laherparepvec, Radiotherapy)

Recruiting
  • Soft Tissue Sarcoma
  • Talimogene Laherparepvec
  • Radiotherapy
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 4, 2022

Melanoma, Merkel Cell Carcinoma, Other Solid Tumors Trial in Middletown, Harrison, New York (TALIMOGENE LAHERPAREPVEC (TVEC),

Active, not recruiting
  • Melanoma
  • +2 more
  • TALIMOGENE LAHERPAREPVEC (TVEC)
  • Hypofractionated Radiotherapy
  • Middletown, New Jersey
  • +2 more
Jul 13, 2022

Soft Tissue Sarcoma Trial in Iowa City (Talimogene Laherparepvec, Radiotherapy)

Active, not recruiting
Has Results
  • Soft Tissue Sarcoma
  • Talimogene Laherparepvec
  • Radiotherapy
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
May 4, 2022

Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)

Completed
Has Results
  • Unresectable Stage IIIB-IV Malignant Melanoma
  • Talimogene laherparepvec
  • Nagoya-shi, Aichi, Japan
  • +8 more
Jan 13, 2023

Metastatic Triple Negative Breast Cancer, Metastatic Colorectal Cancer Trial in Worldwide (Talimogene Laherparepvec,

Completed
Has Results
  • Metastatic Triple Negative Breast Cancer
  • Metastatic Colorectal Cancer
  • Talimogene Laherparepvec
  • Atezolizumab
  • Los Angeles, California
  • +16 more
Nov 22, 2022

Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Zurich (Talimogene Laherparepvec (T-VEC))

Completed
  • Non-melanoma Skin Cancer
  • +4 more
  • Talimogene Laherparepvec (T-VEC)
  • Zurich, Switzerland
    Department of Dermatology, University Hospital Zurich
Mar 17, 2022

Advanced Non CNS Tumors Trial in Worldwide (Talimogene Laherparepvec)

Completed
  • Advanced Non CNS Tumors
  • Talimogene Laherparepvec
  • Wilmington, Delaware
  • +21 more
Dec 21, 2022

Hepatocellular Carcinoma, Liver Metastases, Cutaneous or Subcutaneous Lymph Node Trial in Worldwide (Talimogene Laherparepvec,

Active, not recruiting
Has Results
  • Hepatocellular Carcinoma
  • +3 more
  • Scottsdale, Arizona
  • +31 more
Dec 7, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Active, not recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +21 more
  • Ipilimumab
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Sarcoma Trial in Santa Monica (Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC], Nivolumab IV Soln 100

Recruiting
  • Sarcoma
  • Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC]
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Center
Aug 17, 2021

Angiosarcoma of Skin Trial in Tampa (T-VEC)

Active, not recruiting
  • Angiosarcoma of Skin
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Melanoma and Sarcoma Trial in London (Talimogene laherparepvec (T-VEC))

Completed
  • Melanoma and Sarcoma
  • Talimogene laherparepvec (T-VEC)
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Aug 17, 2021

Malignant Pleural Effusion, Stage IV Metastatic Cancer, Lung Cancer Trial in Chapel Hill (Talimogene laherparepvec (TVEC),

Terminated
Has Results
  • Malignant Pleural Effusion
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Mar 25, 2021

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Tucson, Arizona
  • +39 more
Mar 9, 2022

Squamous Cell Carcinoma, Skin Cancer, Keratoacanthoma Trial in Scottsdale, Tucson (Injection of TVEC into target lesions - week

Recruiting
  • Squamous Cell Carcinoma
  • +5 more
  • Injection of TVEC into target lesions - week 1-2
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Apr 6, 2022

Unresected Stage IIIb to IVM1c Melanoma Trial in Worldwide (Talimogene Laherparepvec)

Completed
Has Results
  • Unresected Stage IIIb to IVM1c Melanoma
  • Talimogene Laherparepvec
  • Salt Lake City, Utah
  • +41 more
Nov 26, 2021

Melanoma Trial in Brussels (CD1c (BDCA-1)+ myDC)

Active, not recruiting
  • Melanoma
  • CD1c (BDCA-1)+ myDC
  • Brussels, Belgium
    UZ Brussel
Dec 28, 2020

Carcinoma of the Head and Neck Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab)

Completed
Has Results
  • Carcinoma of the Head and Neck
  • Talimogene Laherparepvec
  • Pembrolizumab
  • Newark, Delaware
  • +32 more
Aug 13, 2021

Melanoma, BRAF Gene Mutation Trial in Germantown (Talimogene Laherparepvec 1 Million Pfu/Ml Inj,Susp,1Ml,Vil, Talimogene

Unknown status
  • Melanoma
  • BRAF Gene Mutation
  • Talimogene Laherparepvec 1 Million Pfu/Ml Inj,Susp,1Ml,Vil
  • +3 more
  • Germantown, Tennessee
    West Cancer Center
Oct 9, 2020